A key component of treatment for Hodgkin lymphoma is often radiation therapy. In recent decades, however, it has become clear that by integrating chemotherapy with radiation the radiation field can be reduced or even eliminated. The primary reason to do so is to minimize the risk of secondary cancer as a complication of radiation.
Between the late-1960s and the mid-1990s, mantle field radiotherapy (or mantle radiation) was used for some patients because it was the most effective method known at that time to employ radiation. We now know that patients who received mantle radiation have an increased risk of developing breast cancer many years after the radiation was given. Specialists at the BC Cancer Agency, working with diagnostic imaging specialists across BC, have initiated a special monitoring program for patients who received mantle radiation for Hodgkin lymphoma.
In October 2014, the BC Cancer Agency mailed letters to former Hodgkin lymphoma patients who had received mantle radiation to invite them to participate in this higher level of screening. Letters were also mailed to these women’s family physicians. We are encouraging women to bring the letters to their doctors to discuss screening options and arrange for appropriate recommended tests.
For more information on these breast screening recommendations or to discuss your patient’s treatment history with a health care professional from the BC Cancer Agency, please visit www.screeningbc.ca/breast/mantleradiation or call 604 877-6292, toll free 1 800 663-3333, ext. 676292. Additional information is also provided in a related blog published on bcmj.org.
—Christine Wilson, MD
—Stephen Chia, MD
—Laurie Sehn, MD
—Joseph Connors, MD
—Scott Tyldesley, MD
—Karen Goddard, MD
On behalf of the Breast and Lymphoma Tumor Groups at the BC Cancer Agency
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org